These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 33888223)

  • 1. Aspirin Resistance in Obese and Elderly Patients with COVID-19?
    Chiang KC; Gupta A
    Am J Med; 2021 Apr; 134(4):e297. PubMed ID: 33888223
    [No Abstract]   [Full Text] [Related]  

  • 2. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of COVID-19 Transmission from Infected Outpatients to Healthcare Workers in an Outpatient Clinic.
    Chung H; Kim EO; Kim SH; Jung J
    J Korean Med Sci; 2020 Dec; 35(50):e431. PubMed ID: 33372425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 is associated with high viral loads in asymptomatic and recently symptomatic healthcare workers.
    McEllistrem MC; Clancy CJ; Buehrle DJ; Singh N; Lucas A; Sirianni V; Decker BK
    PLoS One; 2021; 16(3):e0248347. PubMed ID: 33735264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.
    Haque S; Jawed A; Akhter N; Dar SA; Khan F; Mandal RK; Areeshi MY; Lohani M; Wahid M
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9244-9245. PubMed ID: 33015764
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of outpatients with only conjunctivitis for SARS-CoV-2 infection during COVID-19 pandemic.
    Uguz FK; Demirkol A; Demirkol Y; Akçay L
    Arq Bras Oftalmol; 2021; 84(2):195-196. PubMed ID: 33787668
    [No Abstract]   [Full Text] [Related]  

  • 7. Can an Old Ally Defeat a New Enemy?
    Gurbel PA; Bliden KP; Schrör K
    Circulation; 2020 Jul; 142(4):315-317. PubMed ID: 32478567
    [No Abstract]   [Full Text] [Related]  

  • 8. High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.
    De Maria A; Varese P; Dentone C; Barisione E; Bassetti M
    J Med Virol; 2020 Nov; 92(11):2310-2311. PubMed ID: 32383174
    [No Abstract]   [Full Text] [Related]  

  • 9. [The prevalence rate of anti-SARS-CoV-2-IgG is 1.2% - Screening in asymptomatic outpatients in Germany (Northrhine-Westfalia)].
    Herrmann BL
    MMW Fortschr Med; 2020 Aug; 162(14):44-46. PubMed ID: 32780376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevention of venous thromboembolism in COVID-19 outpatients].
    Darius H; Grothues J; Haas S; Heinemann M; Klamroth R; Miesbach W
    MMW Fortschr Med; 2021 Apr; 163(8):56-57. PubMed ID: 33904095
    [No Abstract]   [Full Text] [Related]  

  • 11. Acetylsalicylic Acid and COVID-19 Prevention: A Comment.
    Sookaromdee P; Wiwanitkit V
    Clin Appl Thromb Hemost; 2021; 27():10760296211027660. PubMed ID: 34189958
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of obesity on serum levels of SARS-CoV-2-specific antibodies in COVID-19 patients.
    Frasca D; Reidy L; Cray C; Diaz A; Romero M; Kahl K; Blomberg BB
    PLoS One; 2021; 16(3):e0245424. PubMed ID: 33760825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroconversion in household members of COVID-19 outpatients.
    Cox RJ; Brokstad KA; Krammer F; Langeland N;
    Lancet Infect Dis; 2021 Feb; 21(2):168. PubMed ID: 32553187
    [No Abstract]   [Full Text] [Related]  

  • 14. Exposures in adult outpatients with COVID-19 infection during early community transmission, Tennessee.
    Tenforde MW; Feldstein LR; Lindsell CJ; Patel MM; Self WH;
    Influenza Other Respir Viruses; 2021 Jan; 15(1):175-177. PubMed ID: 32755020
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebral Infarction in an Elderly Patient with Coronavirus Disease.
    Alay H; Can FK; Gözgeç E
    Rev Soc Bras Med Trop; 2020; 53():e20200307. PubMed ID: 32520236
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluating the longitudinal effectiveness of preventive measures against COVID-19 and seroprevalence of IgG antibodies to SARS-CoV-2 in cancer outpatients and healthcare workers.
    Fong D; San Nicolò KO; Alber M; Mitterer M
    Wien Klin Wochenschr; 2021 Apr; 133(7-8):359-363. PubMed ID: 33502609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [COVID-toes, a cutaneous sign of innate resistance to SARS-CoV-2].
    Yatim A; Gilliet M
    Rev Med Suisse; 2021 Mar; 17(732):646-652. PubMed ID: 33793103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and Risk of COVID-19 Infection and Severity: Available Evidence and Mechanisms.
    Abiri B; Guest PC; Vafa M
    Adv Exp Med Biol; 2021; 1321():97-107. PubMed ID: 33656716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Remembering Reye's Syndrome in times of COVID-19].
    Conde-Cardona G; Contreras-Puentes N; Polo-Martínez M
    Rev Chilena Infectol; 2020 Nov; 37(5):615-616. PubMed ID: 33399813
    [No Abstract]   [Full Text] [Related]  

  • 20. Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
    Gavillet M; Rolnik DL; Hoffman MK; Panchaud A; Baud D
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):843-844. PubMed ID: 32349165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.